Xinsheng Zhu

机构：Shanghai Pulmonary Hospital, Kashi University · ORCID：0000-0002-5936-607X

发表论文 76 篇 · 总被引 1284 次 · h-index 16

代表论文

• Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer (2024 · Nature Genetics · 被引 146)
• Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II–III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study (2024 · Signal Transduction and Targeted Therapy · 被引 35)
• Injectable and self-healing sulfated hyaluronic acid/gelatin hydrogel as dual drug delivery system for circumferential tracheal repair (2024 · International Journal of Biological Macromolecules · 被引 16)
• Neoadjuvant Aumolertinib for unresectable stage III EGFR-mutant non-small cell lung cancer: a single-arm phase II trial (2025 · Nature Communications · 被引 15)
• Core-shell structured nanomembrane with sequential immune and vascular isolation effects followed by chondrogenic induction to promote stable stem cell-based subcutaneous cartilage regeneration in large animals (2024 · Chemical Engineering Journal · 被引 12)
• Perioperative outcomes of robotic versus video-assisted thoracoscopic surgery in non-small cell lung cancer patients after neoadjuvant chemoimmunotherapy (2024 · Journal of Thoracic Disease · 被引 5)